Praxis Medica
Sign in
Issue image

More articles from Volume 37, Issue 1, 2009

THE EFFECT OF VERAPAMIL ON TRACHEA RESPONSE CAUSED BY HISTAMINE AND ACETILCHOLINE

FLOW/ PRESSURE AND FLOW/ VOLUME CURVES IN DIFFERENTIATION OF THE OBSTRUCTIVE CHANGES IN TRACHEOBRONCHIAL TREE

MICROANA MICROANATOMIC STUDY OMIC STUDY OF THE OPHTHALMIC THE OPHTHALMIC ARTERY

THE ROLE OF STUFF IN TRANSPORT OF CRITICALY ILL OR INJURED PATIENTS IN OUR CONDITIONS

THE ROLE OF STUFF IN TRANSPORT OF CRITICALY ILL OR INJURED PATIENTS IN OUR CONDITIONS

THE MATHEMATICAL MODELS OF ALBUMIN AS DIAGNOSTIC PARAMETERS OF BLOOD-BRAIN BARRIER STATUS

D. Mirić ,
D. Mirić

Institute of Biochemistry, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

View authors publications

Search this author on:

PubMed | Google Scholar
R. Katanić ,
R. Katanić

Institute of Biochemistry, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

View authors publications

Search this author on:

PubMed | Google Scholar
B. Božović ,
B. Božović

Institute of Biochemistry, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

View authors publications

Search this author on:

PubMed | Google Scholar
N. Popović ,
N. Popović

Clinic for Infective Diseases, Clinical Center Pristina, Gracanica

View authors publications

Search this author on:

PubMed | Google Scholar
I. Dragojević
I. Dragojević

Institute of Biochemistry, Medical faculty Pristina , Kosovska Mitrovica , Kosovo*

View authors publications

Search this author on:

PubMed | Google Scholar

Published: 01.01.2009.

Volume 37, Issue 1 (2009)

pp. 39-42;

https://doi.org/10.70949/pramed200901269M

Abstract

The increased protein concentration in cerebrospinal fluid is among most prominent biochemical parameter of intensified passage of macromolecules through blood-brain barrier. It is often found in cases of meningeal inflammation, neurodegeneration, neoplastic and traumatic processes developed on brain or spinal cord structures. Protein concentration in cerebrospinal fluid is often determined, but determination of albumin concentrations as well as mathematical models utilizing albumin are more reflective to the pathologic processes on the brain and spinal cord. Our study was limited to the determination of referent values for our laboratory for cerebrospinal fluid albumin concentrations, albumin quotient, as well as albumin transudat and exudat in the function of the age of probands. The results of the study show great agreement with previously published data.

Keywords

Cerebrospinal fluid,

Brain barrier permeability,

Albumin,

Albumin quotient,

Transudat,

Exudat

References

1.
Neuwelt E, Abbott NJ, L. A. Strategies to advance translational research to blood-brain barrier. Lancet Neurol. 7(1):84–96.
2.
Jacobi C, Reiber H, Hunnemann DH, Hanfeld F. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid. J Neurol. 233:358–61.
3.
Brettschneider J, Claus A, Kassubek J, Tumani H. Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases. J Neurol. 252:1067–73.
4.
Terryberry JW, Schoenfeld Y, B. G. Myelin- and microbe-specific antibodies in Guillain-Barre Syndrome. J Clin Lab Anal. 9:308–19.
5.
Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev. 5:130–45.
6.
Weber RJ, Toumanen IE. Cellular damage in bacterial meningitis: An interplay of bacterial and host driven toxicity. J Neuroimmunol. 184:45–52.
7.
Kettritz R, Choi M, Rolle S, Wellner M, Luft CF. Integrins and cytokines activate nuclear transcription factor B in human neutrophils. J Biol Chem. 279(4):2657–65.
8.
Pfister LA, Tureen HJ, S. S. Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis. Ann Neurol. 47:329–35.
9.
Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol. 20(2):131–40.
10.
V.H P, D.C A, S.J B, H.C B. The blood-brain barrier and the inflammatory response. Mol Med Today. 3:335–41.
11.
Ronquist G, Callerud T, Niklasson F, Friman G. Studies of biochemical markers in cerebrospinal fluid in patients with meningoencephalitis.
12.
Felgenhauer K. Protein size and cerebrospinal fluid composition. Klin Wschr. 36:66–71.
13.
Tourtellotte WW, Ma BI. Multiple sclerosis: The blood-brain barrier and the measurement of de novo central nervous system IgG synthesis. Neurology. 28:76–83.
14.
Reiber H. The Discrimination Between Different Blood-CSF Barrier Dysfunctions and Inflammatory Reactions of the CNS by a Recent Evaluation Graph for the Protein Profile of Cerebrospinal Fluid. J Neurol. 224:89–93.
15.
Seiber A. Plasmaproteinbestimmung durch Laser-Nephelometrie: Laborpraxis. Laboratoriumsblätter. 27:109–18.
16.
Reider HP. Eine neue Modifikation der Cu-Folin-Methode zur Bestimmung des Totalproteins im Liquor cerebrospinalis. Klin Wschr. 44:1036–9.
17.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem. 193:265–70.
18.
Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta. 310:173–86.
19.
Felgenhauer K, Ackermann R, Schilep G. The process dynamics of viral and bacterial diseases of the central nervous system. J Neurol Sci. 47:21–34.

Citation

Copyright

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by
DOAJ
Google Scholar
ERIHPLUS
MIAR I
Crossref